Sort
21,281 grants matching “influenza”
Rapid Acting Vaccine for Pandemic Influenza
$2,691,277Corixa Corporation · UC1 · FY2005 · AI
Center for Research on Influenza Pathogenesis
$2,688,983Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2010 · AI
Structure based design of antibodies and vaccines
$2,688,754James E Crowe · Vanderbilt University Medical Center · U19 · FY2019 · AI
Pathogenesis, Treatment and Prevention of Emerging Infectious Diseases
$2,688,099Clifford Lane · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Enhancing SEBLAB Research Productivity, Operations and Core Laboratory Support
$2,683,615Sixto Manuel Leal · University Of Alabama At Birmingham · UC7 · FY2024 · AI
Membrane Remodeling in Viral Infection and Assembly and Parasite Replication
$2,682,755Joshua Zimmerberg · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2020 · HD
SUPPORT SURVEILLANCE,RESPONSE TO SEASONAL,PANDEMIC INFLUENZA IN WESTERN PACIFIC
$2,682,282Lee Chin-Kei · World Health Organization-West Pacific · U51 · FY2015 · IP
NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR)
$2,682,037Scott Hensley · University Of Pennsylvania · N01 · FY2022 · AI
Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.
$2,680,709Michael G Agadjanyan · Institute For Molecular Medicine · R01 · FY2022 · AG
Live attenuated vaccines for pandemic preparedness
$2,680,016Medimmune Vaccines, Inc. · UC1 · FY2000 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH EFFORTS
$2,670,995Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2018 · AI
Modulation of Biodefense Responses to Microbial Pathogens
$2,669,115Anthony T. Vella · University Of Connecticut Sch Of Med/Dnt · P01 · FY2016 · AI
Modulation of Biodefense Responses to Microbial Pathogens
$2,668,025Anthony T. Vella · University Of Connecticut Sch Of Med/Dnt · P01 · FY2015 · AI
Modulation of Biodefense Responses to Microbial Pathogens
$2,667,494Anthony T. Vella · University Of Connecticut Sch Of Med/Dnt · P01 · FY2017 · AI
Influenza Viral Pathogenesis
$2,667,011Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
CEIRR Influenza Data Processing and Communication Center
$2,664,517Stephan Bour · Digital Infuzion, Inc. · N01 · FY2021 · AI
Mechanisms of Recovery from Viral Pneumonia
$2,662,883Karen M Ridge · Northwestern University At Chicago · P01 · FY2024 · HL
Modulation of Biodefense Responses to Microbial Pathogens
$2,660,765Anthony T. Vella · University Of Connecticut Sch Of Med/Dnt · P01 · FY2014 · AI
Structure-function analysis of infection- and vaccine-induced B-cell repertoires
$2,660,334Stephen C Harrison · Boston Children'S Hospital · P01 · FY2020 · AI
Vaccine and Treatment Evaluation Units (VTEU)
$2,658,055Hana M El Sahli · Baylor College Of Medicine · UM1 · FY2021 · AI
Biodefense and Emerging Infectious Disease and Influenza Vaccine Studies
$2,658,032Lesia Dropulic · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Enhancing SEBLAB Research Productivity, Operations and Core Laboratory Support
$2,655,736Sixto Manuel Leal · University Of Alabama At Birmingham · UC7 · FY2025 · AI
SARS-CoV adaptations through a Systems Biology Lens (SYBIL)
$2,651,463Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U19 · FY2023 · AI
Metabolism, infection and immunity in inborn errors of mitochondrial metabolism
$2,651,175Peter McGuire · National Human Genome Research Institute · ZIA · FY2025 · HG
Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component C: Clinical Core
$2,651,134Justin Ortiz · University Of Maryland Baltimore · N01 · FY2024 · AI